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Background: Epigenetic changes in DNA methylation could regulate the expression of several allergy-related
genes. We investigated whether tolerance acquisition in children with immunoglobulin E (IgE)-mediated cow’s milk
allergy (CMA) is characterized by a specific DNA methylation profile of Th2 (IL-4, IL-5) and Th1 (IL-10, IFN-γ)-associated
cytokine genes.
Results: DNA methylation of CpGs in the promoting regions of genes from peripheral blood mononuclear cells and
serum level of IL-4, IL-5, IL-10 and INF-γ were assessed in children with active IgE-mediated CMA (group 1), in children
who acquired tolerance to cow’s milk proteins (group 2) and in healthy children (group 3). Forty children (24 boys,
aged 3 to 18 months) were enrolled: 10 in group 1, 20 in group 2, and 10 in the control group. The DNA methylation
profiles clearly separated active CMA patients from healthy controls. We observed an opposite pattern comparing
subjects with active IgE-mediated CMA with healthy controls and group 2 children who outgrew CMA. The IL-4
and IL-5 DNA methylation was significantly lower, and IL-10 and INF-γ DNA methylation was higher in active
IgE-mediated CMA patients. Gene promoter DNA methylation rates of all cytokines and respective serum levels
were strongly correlated. Formula selection significantly influenced cytokine DNA methylation profiles in group 2.
Conclusions: Tolerance acquisition in children with IgE-mediated CMA is characterized by a distinct Th1 and Th2
cytokine gene DNA methylation pattern. These results suggest that DNA methylation may be a target for CMA
prevention and treatment.
Keywords: Epigenetics, Interleukin-4, Interleukin-5, Interleukin-10, Interferon-γ, Food allergy, Extensively hydrolyzed
casein formula, Lactobacillus rhamnosus GG, Hypoallergenic formulaeBackground
Cow’s milk allergy (CMA) is one of the most common
food allergies (FA) in early childhood, with an estimated
incidence ranging between 2% and 3% [1]. Evidence
suggests that the natural history of CMA is changing,
with an increasing persistence until later ages [2]. It has
been demonstrated that immunoglobulin E (IgE)-mediated* Correspondence: berni@unina.it
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unless otherwise stated.CMA could be the first manifestation of the so-called
‘atopic march’, characterized by the occurrence of other al-
lergic disorders in the years after the onset of CMA [3].
The pathogenetic basis of IgE-mediated CMA is not
completely understood. Critical to the development of
IgE-mediated chronic allergic inflammation is an in-
creased production of Th2 cytokines, such as interleukins
IL-4 and IL-5, which are not adequately counter-regulated
by Th1 cytokines, such as interferon gamma (IFN-γ) and
IL-10 [4]. We previously found an opposite response pro-
file to these cytokines in freshly isolated peripheral blood
mononuclear cells (PBMCs) between children with activeentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Evidence suggests that CMA is mediated by a combin-
ation of genetic and environmental risk factors. A key
mechanism that governs how environmental exposures
modulate gene expression is DNA methylation of the
cytosine of CpG dinucleotides in the gene-promoter re-
gions, a well characterized epigenetic mechanism [6].
Therefore, the mechanism by which epigenetics contrib-
utes to CMA is a critical issue [7]. Epigenetics is the
study of heritable changes in transcriptional activity that
are not caused by changes in DNA sequence [8,9]. Epi-
genetic marks, such as DNA methylation, seem to work
with other components of the cellular regulatory ma-
chinery to control the level of genes expression, and
several allergy-related genes have been found to be
susceptible to epigenetic regulation, including genes im-
portant for T-effector pathways, namely IFN-γ and IL-4
[7,10]. Preliminary data showed that epigenetic modifi-
cations at the Th2 locus could be responsible for the
establishment, maintenance, and inheritance of the Th2
phenotype, while altered epigenetic regulation is poten-
tially important for the exaggerated Th2 response seen
in atopic diseases [11]. Decreased DNA methylation and
an increased association with activating histone marks
conjointly establish and maintain the euchromatin struc-
ture at the Th2 locus of Th2 cells, thereby allowing re-
cruitment of the transcriptional machinery to this region
for a rapid and coordinated expression of the Th2-related
cytokines [12-14]. Hypermethylation of IFN-γ has been
positively correlated with pro-allergic IgE production [15].
As DNA methylation is a reversible mechanism and can
be changed during disease course [16-19], we evaluated
whether tolerance acquisition in children with IgE-
mediated CMA is characterized by a specific DNA
methylation profile of cytokine genes associated with
Th2 (IL-4, IL-5) and Th1 (IL-10, IFN-γ) response.
Results
Study subjects
From 3 December 2012 to 30 April 2014, 13 consecutive
children with a recent evidence of IgE-mediated CMA
were evaluated. All these patients presented with sus-
pected CMA-related signs and symptoms within 5 weeks
of study enrollment. Three were excluded because a
negative oral food challenge. The ten remaining patients
(group 1) were positive at the double blind placebo con-
trolled food challenge (DBPCFC) and reacted between at
doses 3 and 10 ml. During the same period, 20 subjects
with a previous diagnosis of IgE-mediated CMA, but with
recent evidence of oral tolerance acquisition demonstrated
by a negative DBPCFC were also enrolled in the study
(group 2). All subjects were able to consume at least one
full cup daily of cow’s milk without symptoms. Group 2
patients, received for a median of 384 days (IQR 7.75) oneof the following substitutive formulae: extensively hydro-
lyzed casein formula (EHCF, n = 3); extensively hydrolyzed
casein formula containing the probiotic Lactobacillus
rhamnosus GG (EHCF + LGG, n = 10); hydrolyzed rice
formula (RHF, n = 1); soy formula (SF, n = 3); amino acid-
based formula (AAF, n = 3). During the same period, ten
healthy children were evaluated and their parents gave in-
formed consent to the study. The main demographic and
clinical characteristics of the study population are detailed
in Table 1.
Cytokines DNA methylation profiles
Figure 1 shows the promoter DNA methylation profiles
of IL-4, IL-5, IL-10, and INF-γ from PBMCs in the three
study groups. The DNA methylation profiles clearly sep-
arated active CMA patients from healthy controls. We
observed an opposite pattern between children with ac-
tive IgE-mediated CMA and healthy controls. The DNA
methylation of IL-4 and IL-5 was lower and of IL-10 and
IFN-γ was higher in active CMA patients than in healthy
controls (Figure 1A, B, C, D). DNA methylation analysis
of these cytokine genes clearly also separated CMA pa-
tients by disease-state. Subjects with recent evidence of
oral tolerance acquisition presented a different methyla-
tion profile if compared to active CMA patients. This
profile was similar but not identical to that observed in
healthy controls (Figure 1A, B, C, D). The backward
stepwise Firth regression analysis showed that the best
predictor of active CMA was the IL-5 methylation rate
(healthy controls vs active CMA: coefficient −0.151, SE
0.058; P < 0.0001; active CMA vs patients who outgrew
CMA: coefficient 0.5419, SE 0.2518; P < 0.0001).
We analyzed, through a linear regression analysis, po-
tential factors (age, sex, serum IgE, specific serum IgE
anti-epitopes, symptoms, formulae) able to influence IL-5
DNA methylation rate in subjects who outgrew CMA.
The variable that most affected the DNA methylation rate
of cytokines was the use of the EHCF + LGG formula (co-
efficient −17.761, SE 3.86, P = 0.004). Accordingly, patients
who outgrew CMA after EHCF + LGG treatment pre-
sented a different cytokine methylation pattern compared
to children treated with other formulae (Figure 2).
Cytokine serum levels
We evaluated whether DNA methylation in the promoter
region negatively correlated with the serum concentration
of IL-4, IL-5, IL-10, and INF-γ of the three study groups.
The DNA methylation rate of all cytokines significantly
correlates with the respective serum concentration
(Figure 3A, B, C, D). Active IgE-mediated CMA pa-
tients showed significantly higher IL-4 and IL-5 and
significantly lower IL-10 and INF-γ serum levels com-
pared to healthy controls (Figure 4A, B, C, D). Subjects
with a recent evidence of oral tolerance acquisition
Table 1 Main demographic and clinical characteristics of the study population
Subjects with CMA at diagnosis Subjects outgrown CMA Healthy subjects
Group 1 Group 2 Group 3
N 10 20 10
Male, n (%) 7 (70) 13 (65) 4 (40)
Age, m (SD) 5.5 (0.7) 16.9 (0.9) 9 (4)
Body weight, kg (SD) 7.385 (964.7) 12.160 (720.9) 8.075 (3193.5)
Spontaneous delivery, n (%) 5 (50) 5 (25) 4 (40)
Breastfeeding, ≤8 weeks, n (%) 10 (100) 20 (100) 10 (100)
Symptoms at the CMA onset
Gastrointestinal, n (%) 4 (40) 8 (40) -
Cutaneous, n (%) 8 (80) 15 (75) -
Respiratory, n (%) 1 (10) 6 (30) -
Total serum IgE, kU/l (SD) 260.6 (230.9) 193.1 (209.5) 0.2 (0.1)
nBos d 4, kUA/l (SD) 6 (11.2) 1.9 (3) -
nBos d 5, kUA/l (SD) 4.5 (7.1) 2 (3) -
nBos d 6, kUA/l (SD) 5.4 (8.7) 1.4 (2.5) -
nBos d 8, kUA/l (SD) 22.7 (39.2) 0.9 (1.9) -
Lactoferrin, kUA/l (SD) 2 (6.1) 0 -
Berni Canani et al. Clinical Epigenetics  (2015) 7:38 Page 3 of 9presented a different profile compared to active CMA
patients. This profile was similar to that observed in
healthy controls (Figure 4).
Discussion
We found that oral tolerance acquisition in children
with IgE-mediated CMA is characterized by an epigen-
etic regulation involving Th1 and Th2 cytokine genes.
The rate of DNA methylation in Th1 and Th2 cytokine
gene promoters in PBMCs differed significantly between
active CMA children and children who outgrew CMA.
The two groups showed an inverse DNA methylation
pattern of the IL-4, IL-5, IL-10, and IFN-γ genes. More-
over, a strong correlation between gene promoter DNA
methylation rates of all cytokines was observed with the
respective serum levels. The link between DNA methyla-
tion and gene expression has been explored in in vitro
studies [20,21]. In a study of CD4+T lymphocytes of
patients with asthma, stimulated with allergens, there
was a significant correlation between the degree of
methylation and IL-4 concentration [22]. Lovinsky-Desir
et al. found a negative correlation between the DNA
methylation rate of the IFN-γ promoter in CD4 + T lym-
phocytes and the relative IFN-γ gene expression in a co-
hort of children and adults with allergic asthma [23]; a
similar negative correlation between IFN-γ DNA methy-
lation and gene expression of T effector cells was re-
ported by Kohli et al. in children exposed to secondhand
smoke and air pollution [24]. Our study is the first to
compare methylation status of Th1 and Th2 cytokinegenes in children affected by IgE-mediated CMA at
different disease stage. Martino et al. retrospectively
examined genome-wide DNA methylation profiles in
CD4+T cells from a birth cohort of children with IgE-
mediated food allergy and age-matched non-allergic
controls at birth and at age 12 months [25]. They
found dysregulation of DNA methylation of MAPK
signaling-associated genes during early CD4+T cell de-
velopment. They suggested that this may contribute to
a suboptimal T-lymphocyte response in early child-
hood potentially associated to the development of food
allergy. The use of epigenetic biomarkers, mainly based
on DNA methylation, is well established for the diag-
nosis and prognosis of tumors and has begun to be
understood in other conditions such as autoimmune
diseases [26]. The identification of DNA methylation
marks in immune-function-related genes could en-
courage the development of new epigenetic-based-
biomarkers that could have direct application in food
allergy. DNA methylation level of selected Th1 and
Th2 cytokines genes could be used as a potential bio-
marker in predicting tolerance acquisition. In this view,
Syed et al. showed that the FOXP3 DNA methylation rate
decreased during successful oral immunotherapy in pa-
tients with peanut allergy and remain stable when oral
tolerance is achieved [27]. In accordance with these data,
our results suggest that in IgE-mediated CMA children,
the DNA methylation of the Th1 and Th2 cytokine
genes is a dynamic process with substantial differences
occurring during the disease course. The magnitude of
Figure 2 Different DNA methylation rates of the IL-4, IL-5, IL-10, INF-γ genes in children who outgrew CMA receiving different dietary
treatment. Children, who outgrew CMA after EHCF + LGG treatment, presented a different cytokines methylation profile compared to children
treated with other formulae.
A B
C D
Group 1, active CMA children
Group 2, children who outgrew CMA
Group 3, healthy controls
The p-values remain significant after Bonferroni correction
Figure 1 DNA methylation rate of the IL-4, IL-5, IL-10, and INF-γ genes (A, B, C, D, respectively) observed in the study population. The
rate of promoter gene methylation of IL-4 and IL-5 was lower and IL-10 and IFN-γ was higher in group 1 than group 3. Group 2 presented a
methylation rate similar to that observed in group 3. (group 3 vs group 1: coefficient −0.151, SE 0.058; P < 0.0001; group 1 vs group 2: coefficient
0.542, SE 0.2518; P < 0.0001).
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p<0.0001
Figure 3 Correlation between IL-4, IL-5, IL-10, and INF-γ gene DNA methylation rate and cytokine respective serum levels observed in
groups 1, 2, and 3 (A-D). There is a negative and significant correlation between the DNA methylation rate and the respective serum
concentration for all cytokines.
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the basis for a potential use of these epigenetic marks as
biomarkers of disease status.
In our study, the DNA methylation rate of the Th1
and Th2 cytokine genes differed significantly between
CMA children treated with EHCF containing the pro-
biotic Latobacillus rhamnosus GG, who acquired oral
tolerance, and CMA children treated with other formu-
lae. Among the factors potentially influencing DNA
methylation rate in subjects who outgrew CMA, the
strongest variable was EHCF + LGG treatment. This find-
ing supports the use of these epigenetic marks as potential
therapeutic biomarkers for dietary intervention. Interest-
ingly, similar epigenetic effects have been reported for the
farm-derived bacteria Acinetobacter lwoffli F78 in a mouse
model of ovalbumin-induced asthma [28].
The main limitations of our study are the relative
small number of children and cytokines evaluated and
the cross-sectional design. Longitudinal cohort studies
in CMA children from the onset of symptoms to the
acquisition of oral tolerance are advocated. Another
limitation is the PBMCs-based epigenetic evaluations.
Given the small amounts of blood, as expected in a
study of very young children, cell sorting was not pos-
sible. Although CMA is a systemic condition, for whichthe study of methylation patterns in whole blood may be
feasible [10,19], we cannot exclude the possibility that
blood cell heterogeneity may have exerted a confounding
effect.
Conclusions
While genetics may play a role in CMA, it cannot
explain the rapid epidemiological changes occurred in
recent decades. There is a growing recognition that the
epigenome is a key missing piece of CMA pathogenesis
puzzle [10]. Our findings suggest that DNA methylation
plays a role in tuning the course of CMA and dietary
interference with epigenetic mechanisms might repre-
sent an innovative approach to target the development
of oral tolerance.
Methods
Study population
We planned to enroll two categories of IgE-mediated
CMA patients (aged 3 to 18 months) consecutively
referred to our tertiary Center for Pediatric Food Allergy
because of the necessity of an oral food challenge: i.
patients with recent evidence of IgE-mediated CMA
(‘active CMA patients’, group 1); and ii. patients with a
previous diagnosis of IgE-mediated CMA, but with
A B Group 1, active CMA children
Group 2, children who outgrew CMA
Group 3, healthy controls
D
The p-values remain significant after Bonferroni correction
C
Figure 4 Serum concentration of IL-4, IL-5, IL-10, and INF-γ (pg/ml) observed in groups 1, 2, and 3 of the study population (A-D).
Group 1 had showed significantly higher IL-4 and IL-5 and significantly lower IL-10 and INF-γ serum levels compared to group 3. Group 2
presented different levels of all cytokines compared to group 1 and a similar level to that observed in group 3.
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outgrew CMA’, group 2).
In all patients, oral food challenge was requested to
obtain diagnosis of CMA (group 1) or evidence of oral
tolerance acquisition (group 2). The diagnosis of IgE-
mediated CMA was made in all subjects according to
the result of a (DBPCFC, namely, occurrence of typical
symptoms within 2 h of the administration of the last
dose) and the outcomes of diagnostic work-up, that is, a
clear clinical history of typical IgE-mediated symptoms
of CMA, and positive specific serum IgE against proteins
and epitopes of cow’s milk [29]. Patients with a negative
DBPCFC (group 2) were reassessed after 4 weeks to
check the persistence of clinical tolerance. A venous
blood sample (4 ml) was obtained in all patients at the
end of the DBPCFC procedure for serological test and
epigenetic analysis. Th1 and Th2 cytokine dosage and
PBMCs sorting were carried out with the same blood
sample. Subjects with other allergic disorders or food
allergies, eosinophilic disorders of the gastrointestinal tract,
food protein-induced enterocolitis syndrome, concomitantchronic systemic diseases, congenital cardiac defects,
active tuberculosis, autoimmune diseases, immuno-
deficiency, chronic inflammatory bowel diseases, celiac
disease, cystic fibrosis, metabolic diseases, lactose in-
tolerance, malignancy, chronic pulmonary diseases,
and malformations of the gastrointestinal tract were
excluded. As controls, during the same study period,
consecutive healthy children, not at risk for atopic
disorders (that is, without any first degree family mem-
ber affected by atopic disorders), visiting our Center
because of minimal surgical procedures were also enrolled
(group 3). A venous blood sample (4 ml) was collected
from all these healthy subjects. These children were also
assessed for the presence of food allergy and other allergic
diseases at enrollment and 6 months after blood sampling
by experienced pediatric allergists operating at the Center.
The medical record of each child was recorded on a clinical
chart. The study was approved by the Ethics Committee of
the University of Naples ‘Federico II’ and was registered in
Clinical Trials Protocol Registration System (ID number:
NCT02062476).
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All food challenges were performed by DBPCFC, as pre-
viously described [30]. All oral food challenges took
place at our Center on two separate days with a 1-week
interval. Parents of children taking antihistamine were
advised to withhold these medications for at least 72 h
before and during the challenge. Randomization and
preparation of the challenges were performed by experi-
enced food allergy dieticians not directly involved in the
procedures. Briefly, every 20 min, successive doses (0.1,
0.3, 1, 3, 10, 30, and 100 ml) of fresh pasteurized CM
containing 3.5% fat or an amino acid-based formula
were administered. Full emergency equipment and medi-
cations (epinephrine, antihistamines, and steroids) were
available. The results were assessed simultaneously by
three experienced pediatric allergists. Study subjects were
scored for nine items divided into four main categories: i.
General (lowered blood pressure plus tachycardia); ii. Skin
(rash, urticaria/angioedema); iii. Gastrointestinal (nausea/
repeated vomiting, crampy-like abdominal pain, diarrhea);
and iv. Respiratory (sneezing/itching, nasal congestion/
rhinorrhea, stridor deriving from upper airway obstruction
or wheezing) on a 0- to 3-point scale (0, none; 1, light; 2,
moderate; and 3, severe). If at least two of the three physi-
cians independently scored any item at level 3, or 2 (or
more) items at level 2, the test result was considered posi-
tive. Clinical symptoms occurring within 2 h of adminis-
tering the highest dose were defined as ‘IgE-mediated
reactions.’ The infants were observed for 2 h after the final
dose, and then discharged. In the case of a positive
DBPCFC, at any testing dose, the patient remained under
observation until symptom resolution. If the patient did
not show any symptom within the first 24 h, parents were
advised to give one single feed of 100 ml of the tested for-
mula (verum or placebo) everyday at home for 7 days. If
any symptom occurred during this period, the patient
returned to the outpatient clinic on the same day. After
7 days of verum or placebo administration, the patients
were examined and the parents interviewed at the Center.
To rule out a false-negative challenge result, parents were
asked to contact the Center if any symptoms occurred in
the 7 days after the DBPCFC procedures. The challenge was
considered negative if the patient tolerated the entire chal-
lenge, including the observation period. Clinical tolerance
acquisition was defined by the presence of a negative
DBPCFC. The persistence of tolerance acquisition was
checked after 4 weeks in all subjects with negative DBPCFC.
Total IgE and specific IgE against proteins and epitopes
of cow’s milk
Serum was obtained by centrifugation for 10 to 15 min.
Serum was flash frozen and stored at −80°C until ana-
lysis. Serum total IgE and specific IgE against epitopes of
cow’s milk were analyzed by enzymatic immunoassay(Phadia 100 ThermoFisher Scientific CAP system, Rodano
Milano, Italy).
Measurement of serum IL-4, IL-5, IL-10, and IFN-γ
concentration
Serum samples were flash frozen and stored at −80°C
until further analysis. The concentrations of IL-4 and
IL-10 were measured with a Human IL4/IL10 Enzyme
immunoassay kit (Boster Biological Technology, Ltd.,
Fremont, CA, USA) according to the type of stimulation
and stimulant. Human IL-5 and IFN-γ ELISA, High
Sensitivity (BioVendor, Brno, Czech Republic) were
used to detect the IL-5 and IFN-γ serum concentrations.
Absorbance was read at 450 nm. The minimum detec-
tion concentrations were 15.6 pg/ml for IL-4, 7.8 pg/ml
for IL-5 and IL-10, and 0.78 pg/ml for IFN-γ.
Leucocytes isolation, DNA extraction, and bisulfite
modification
PBMCs were isolated from whole blood samples using
the Ficoll-Paque (GE Healthcare, Uppsala, Sweden)
methods. DNA was extracted using the DNA Extraction
Kit (GE Healthcare). One microgram of extracted DNA
was modified with sodium bisulfite to convert all
unmethylated, but not methylated-cytosines to uracil.
Bisulfite conversion was carried out using the EZ DNA
Methylation Gold Kit (ZYMO Research Co., Orange,
CA, USA), according to the manufacturer’s instruc-
tions. The converted DNA was stored at −70°C until
used. Fully methylated and fully unmethylated DNA
(Merck Millipore, Darmstadt, Germany) were used as
controls for the optimization of the assay conditions
and to calculate the percent of methylation (0% to
100%). The primer used for DNA methylation analysis
of the promoter region of the IL-4, IL-5, IL-10, and
IFN-γ genes was designed in silico, using MethPrimer
(http://www.urogene.org/methprimer/) (Table 2).
High-resolution melting real-time PCR and sequencing
Real-time PCR was performed with the LightCycler® 480
instrument (Roche Applied Science, Penzberg, Germany)
using 96-well plates (Roche Applied Science). Extensive
optimization experiments were performed in order to
maximize PCR amplification efficiency, including PCR
program parameters, Mg2+, primer and template concen-
trations. Sodium bisulfite-converted DNA (15 ng) was
added to the PCR reaction mix, which consisted of high-
resolution melting Master Mix (Roche Applied Science),
0.25 μM primers, and Mg2+ (2.5 mM). dH2O was used to
supplement up to 20 μl. The real-time PCR protocol
began with one cycle at 95°C for 10 min followed by
40 cycles of 95°C for 10 s, 61°C for 10 s, and 72°C for
10 s. Immediately after amplification, a re-annealing
cycle consisting of 95°C for 1 min and a rapid cooling
Table 2 The primer sequences used for high-resolution melting real-time PCR analysis
Primers Sequence (5′-3′) PCR product size (bp) CpG sites (n)
IL-4 F AGGTTAGGAGATGGAGATTATTTTG 102 4
IL-4 R TAAAACTACAAACACCTACCACCAC
IL-5 F AGGTTAGGAGATGGAGATTATTTTG 102 5
IL-5 R TAAAACTACAAACACCTACCACCAC
IFN-γ F GAGTTTTGTTTTGTTATTTAGGTTGG 124 6
IFN-γ R AATACCTATAATCCCAACTACTC
IL-10 F TTTATTGTGTTAATTAGGATGGTTT 154 7
IL-10 R TAAACAAAAATCCAAAATACTTTTT
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ing curve acquisition step. Real-time fluorescence ac-
quisition was set at the elongation step (72°C). Samples
whose amplification begun late and sample whose rela-
tive fluorescence value on the raw melting-curve plot
was low were not further processed. All PCR reactions
were performed in triplicate for each sample. Melting
data acquisition began at 69°C and ended in 95°C,
using a ramp rate of 0.2°C/s. High-resolution melting
analysis was also performed with the LightCycler® 480
instrument (Roche Applied Science) using 96-well
plates (Roche Applied Science). Data processing included
normalization and resulted on the normalized melting
curves and the respective negative derivative of fluores-
cence over the temperature plots, using the LightCycler
480® gene scanning software. The settings for data collec-
tion were 50 fluorescence acquisition points per degree
centigrade resulting on a ramp rate of 0.01°C/s. Compari-
son of the melting curve or the peaks of an unknown sam-
ple with those of the controls gave the semi-quantitative
estimation for the methylation level of that sample. The
results were confirmed by direct sequencing (Sanger
method modified: ddNTPs labeled with four different
fluorophores) and analyzed by capillary electrophoresis
(analytical specificity and sensitivity of the test: >99%).
Statistical analysis
The Kolmogorov-Smirnov test was used to determine
whether variables (cytokine DNA methylation rates and
serum levels of cytokines and IgE) were normally dis-
tributed. Serum levels of cytokines and IgE were not
normally distributed (Kolmogorov-Smirnov test; P < 0.05)
and thus were 10 log-transformed (Kolmogorov-Smirnov
test; P > 0.05).
The χ2 test and Fisher’s exact test were used for cat-
egorical variables. To evaluate the differences among
continuous variables, one-way ANOVA and the t-test
were performed. To determine which groups in the sam-
ple differ, the Bonferroni correction was performed.
Pearson’s correlation coefficient ‘r’ was used to evaluate
the correlation between continuous variables.Given the small sample size and relative issues of sep-
arability, a backward stepwise Firth’s bias reduced logis-
tic regression was used to identify the best predictor of
the CMA disease state [31]. This analysis was performed
with the R package ‘logistf ’. Linear regression was used
to estimate the relationship between continuous vari-
ables. The level of significance for all statistical tests was
two-sided, P < 0.05. All data were recorded in a dedi-
cated database and analyzed by a statistician, blinded to
the group assignment of patients, with SPSS software
(SPSS Inc, version 21.0, Chicago, IL, USA).
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